Temecula, CA, October 22, 2013 --(PR.com
)-- CVAC Systems, Inc. today announced the publication of a paper on a sham-controlled study which showed that the use of its Cyclic Variations in Adaptive Conditioning™ (CVAC™) process significantly lowered fasting blood glucose levels in a group of middle-aged men.
The paper, entitled "Cyclic Hypobaric Hypoxia Improves Markers of Glucose Metabolism in Middle-Aged Men," published in the September 2013 issue of High Altitude Medicine & Biology, showed that using the CVAC pod for 120 minutes each week for a period of 10 weeks, significantly lowered fasting blood glucose levels in a group of sedentary middle-aged men. The study was performed at Veterans Affairs Palo Alto Health Care System by investigators from Stanford University.
Researchers studied the impact of the CVAC process on two groups. One group of 11 men received CVAC sessions while the remaining 10 subjects received sham CVAC sessions. The men taking CVAC sessions had a significant reduction in fasting blood glucose ( p < 0.05) and a significant decrease in blood glucose during an oral glucose tolerance test after 10 weeks. There were no significant changes in the control group.
These improvements occurred without any accompanying changes in body weight, timed walk test, or self-reported physical activity levels, according to the study investigators.
Lack of physical activity and being overweight are closely linked risk factors of pre-diabetes and type 2 diabetes. Healthcare providers routinely recommend exercise to their patients to prevent pre-diabetes, diabetes and associated complications of diabetes. The estimated total cost of diagnosed diabetes was $245 billion in 2012, according to the American Diabetes Association.
“This paper suggests that the fitness derived from the CVAC process can improve glucose homeostasis similar to exercise. Larger studies are needed to determine if the CVAC process can decrease the progression from pre-diabetes to diabetes similar to regular exercise. If this can be determined, then the CVAC process could hold the potential for people to experience benefits similar to exercise while sitting,” commented Karen Herbst, PhD, MD, board-certified Endocrinologist and Chairperson of CVAC Systems, Inc. Scientific Advisory Board.
“We are excited because this is the first published data on the CVAC process that is relevant to the general population. Arguably, anyone born today is at risk for diabetes,” commented Craig Wagstaff, President and COO of CVAC Systems, Inc.
About the CVAC process and CVAC Systems, Inc.
The CVAC process is intended to provide adaptation-based physical conditioning via dynamically cycled changes in reduced atmospheric pressure, temperature and air density.
The body responds to these changes similarly to how it responds to exercise.
CVAC Systems, Inc., developer of the patented CVAC technology, is a privately held company headquartered in Temecula, California.